Bank of New York Mellon
CNTB

Bank of New York Mellon’s Connect Biopharma Holdings CNTB Stock Holding History

Bank of New York Mellon’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57K Buy
+23,953
New +$58.1K ﹤0.01% 4237

Other funds holding CNTB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Bank of New York Mellon's CNTB Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 23,953 shares worth $57K. The stake represents ﹤0.01% of the portfolio and ranks #4237 among its holdings.

24 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Bank of New York Mellon held 23,953 shares of Connect Biopharma Holdings worth $57K as of Q2 2026.
  • Connect Biopharma Holdings was a new Bank of New York Mellon position in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4237 holding.
  • 24 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.